Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2018

Open Access 01-12-2018 | Research article

Positive impact of retrograde autologous priming in adult patients undergoing cardiac surgery: a randomized clinical trial

Authors: Britt Hofmann, Claudia Kaufmann, Markus Stiller, Thomas Neitzel, Andreas Wienke, Rolf-Edgar Silber, Hendrik Treede

Published in: Journal of Cardiothoracic Surgery | Issue 1/2018

Login to get access

Abstract

Background

Adult cardiac surgery with extracorporeal circulation is known to be associated with increased risk of blood transfusion leading to adverse outcomes. Procedures like retrograde autologous priming (RAP) may reduce these negative side effects. This randomized prospective study was initiated to assess whether RAP using specifically designed RAP bag (Terumo) has immediate effects on patient outcome.

Methods

One hundred eighteen adults undergoing elective CABG or elective aortic valve replacement were randomly assigned by a computer program into two groups: the RAP group (n = 54) in which the retrograde autologous priming was applied and the non-RAP (n = 64) group in which the same setting was used without the possibility to save priming volume. Patient demographics, preoperative characteristics and postoperative outcomes were analyzed for both groups.

Results

The primary endpoint defined as rate of intraoperative blood transfusion was significantly reduced in the RAP-group (p = 0.04). The absolute risk reduction for RAP managed patients was 13.5 percent points. There were no significant differences in operation time and blood loss. No deaths and no myocardial infarctions were observed. The number of patients needed to treat to prevent at least one red blood cell transfusion was around 8 (NNT = 7.42).

Conclusions

Retrograde autologous priming is a safe and less invasive procedure which achieves clear benefits for adult cardiac surgery patients. In the light of increasing red blood cell transfusion risks and costs and the wish of patients to avoid a transfusion implementation of retrograde autologous priming is an interesting option.

Trial registration

German Clinical Trials Register ID: DRKS00013512, registered 04 December 2017.
Literature
1.
2.
go back to reference Neitzel T, Stiller M, Bushnaq H. Statistische Analyse der in Deutschland durchgeführten Perfusionen - Ergebnisse einer Umfrage 2013. Kardiotechnik. 2014;10:12–22. Neitzel T, Stiller M, Bushnaq H. Statistische Analyse der in Deutschland durchgeführten Perfusionen - Ergebnisse einer Umfrage 2013. Kardiotechnik. 2014;10:12–22.
3.
go back to reference Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed. J Thorac Cardiovasc Surg. 2003;125(6):1438–50.CrossRefPubMed Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed. J Thorac Cardiovasc Surg. 2003;125(6):1438–50.CrossRefPubMed
4.
go back to reference Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, Djaiani G, Ivanov J, Karski J, David TE. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005;129(2):391–400.CrossRefPubMed Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, Djaiani G, Ivanov J, Karski J, David TE. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005;129(2):391–400.CrossRefPubMed
5.
go back to reference Loor G, Li L, Sabik JF 3rd, Rajeswaran J, Blackstone EH, Koch CG. Nadir hematocrit during cardiopulmonary bypass: end-organ dysfunction and mortality. J Thorac Cardiovasc Surg. 2012;144(3):654–62. e654CrossRefPubMed Loor G, Li L, Sabik JF 3rd, Rajeswaran J, Blackstone EH, Koch CG. Nadir hematocrit during cardiopulmonary bypass: end-organ dysfunction and mortality. J Thorac Cardiovasc Surg. 2012;144(3):654–62. e654CrossRefPubMed
6.
go back to reference Horvath KA, Acker MA, Chang H, Bagiella E, Smith PK, Iribarne A, Kron IL, Lackner P, Argenziano M, Ascheim DD, et al. Blood transfusion and infection after cardiac surgery. Ann Thorac Surg. 2013;95(6):2194–201.CrossRefPubMedPubMedCentral Horvath KA, Acker MA, Chang H, Bagiella E, Smith PK, Iribarne A, Kron IL, Lackner P, Argenziano M, Ascheim DD, et al. Blood transfusion and infection after cardiac surgery. Ann Thorac Surg. 2013;95(6):2194–201.CrossRefPubMedPubMedCentral
7.
go back to reference Teman N, Delavari N, Romano M, Prager R, Yang B, Haft J. Effects of autologous priming on blood conservation after cardiac surgery. Perfusion. 2014;29(4):333–9.CrossRefPubMed Teman N, Delavari N, Romano M, Prager R, Yang B, Haft J. Effects of autologous priming on blood conservation after cardiac surgery. Perfusion. 2014;29(4):333–9.CrossRefPubMed
8.
go back to reference Ranucci M, Baryshnikova E, Castelvecchio S, Pelissero G. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg. 2013;96(2):478–85.CrossRefPubMed Ranucci M, Baryshnikova E, Castelvecchio S, Pelissero G. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg. 2013;96(2):478–85.CrossRefPubMed
9.
go back to reference Stokes EA, Wordsworth S, Bargo D, Pike K, Rogers CA, Brierley RC, Angelini GD, Murphy GJ, Reeves BC. Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial. BMJ Open. 2016;6(8):e011311.CrossRefPubMedPubMedCentral Stokes EA, Wordsworth S, Bargo D, Pike K, Rogers CA, Brierley RC, Angelini GD, Murphy GJ, Reeves BC. Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial. BMJ Open. 2016;6(8):e011311.CrossRefPubMedPubMedCentral
10.
go back to reference Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, Reeves BC. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;372(11):997–1008.CrossRefPubMed Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, Reeves BC. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;372(11):997–1008.CrossRefPubMed
11.
go back to reference Honemann C, Bierbaum M, Heidler J, Doll D, Schoffski O. Costs of delivering allogenic blood in hospitals. Chirurg. 2013;84(5):426–32.CrossRefPubMed Honemann C, Bierbaum M, Heidler J, Doll D, Schoffski O. Costs of delivering allogenic blood in hospitals. Chirurg. 2013;84(5):426–32.CrossRefPubMed
12.
go back to reference Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, Song HK, Clough ER, Shore-Lesserson LJ, Goodnough LT, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91(3):944–82.CrossRefPubMed Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, Song HK, Clough ER, Shore-Lesserson LJ, Goodnough LT, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91(3):944–82.CrossRefPubMed
13.
go back to reference Panico FG, Neptune WB. A mechanism to eliminate the donor blood prime from the pump-oxygenator. Surg Forum. 1960;10:605–9.PubMed Panico FG, Neptune WB. A mechanism to eliminate the donor blood prime from the pump-oxygenator. Surg Forum. 1960;10:605–9.PubMed
14.
go back to reference Rosengart TK, DeBois W, O'Hara M, Helm R, Gomez M, Lang SJ, Altorki N, Ko W, Hartman GS, Isom OW, et al. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg. 1998;115(2):426–38. discussion 438-429CrossRefPubMed Rosengart TK, DeBois W, O'Hara M, Helm R, Gomez M, Lang SJ, Altorki N, Ko W, Hartman GS, Isom OW, et al. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg. 1998;115(2):426–38. discussion 438-429CrossRefPubMed
15.
go back to reference Eising GP, Pfauder M, Niemeyer M, Tassani P, Schad H, Bauernschmitt R, Lange R. Retrograde autologous priming: is it useful in elective on-pump coronary artery bypass surgery. Ann Thorac Surg. 2003;75(1):23–7.CrossRefPubMed Eising GP, Pfauder M, Niemeyer M, Tassani P, Schad H, Bauernschmitt R, Lange R. Retrograde autologous priming: is it useful in elective on-pump coronary artery bypass surgery. Ann Thorac Surg. 2003;75(1):23–7.CrossRefPubMed
16.
go back to reference Sobieski MA 2nd, Slaughter MS, Hart DE, Pappas PS, Tatooles AJ. Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use. Perfusion. 2005;20(1):31–7.CrossRefPubMed Sobieski MA 2nd, Slaughter MS, Hart DE, Pappas PS, Tatooles AJ. Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use. Perfusion. 2005;20(1):31–7.CrossRefPubMed
17.
go back to reference Reges RV, Vicente WV, Rodrigues AJ, Basseto S, Alves Junior L, Scorzoni Filho A, Ferreira CA, Evora PR. Retrograde autologous priming in cardiopulmonary bypass in adult patients: effects on blood transfusion and hemodilution. Rev Bras Cir Cardiovasc. 2011;26(4):609–16.CrossRefPubMed Reges RV, Vicente WV, Rodrigues AJ, Basseto S, Alves Junior L, Scorzoni Filho A, Ferreira CA, Evora PR. Retrograde autologous priming in cardiopulmonary bypass in adult patients: effects on blood transfusion and hemodilution. Rev Bras Cir Cardiovasc. 2011;26(4):609–16.CrossRefPubMed
18.
go back to reference Severdija EE, Heijmans JH, Theunissen M, Maessen JG, Roekaerts PH, Weerwind PW. Retrograde autologous priming reduces transfusion requirements in coronary artery bypass surgery. Perfusion. 2011;26(4):315–21.CrossRefPubMed Severdija EE, Heijmans JH, Theunissen M, Maessen JG, Roekaerts PH, Weerwind PW. Retrograde autologous priming reduces transfusion requirements in coronary artery bypass surgery. Perfusion. 2011;26(4):315–21.CrossRefPubMed
19.
go back to reference Trapp C, Schiller W, Mellert F, Halbe M, Lorenzen H, Welz A, Probst C. Retrograde autologous priming as a safe and easy method to reduce Hemodilution and transfusion requirements during cardiac surgery. Thorac Cardiovasc Surg. 2015;63(7):628–34.CrossRefPubMed Trapp C, Schiller W, Mellert F, Halbe M, Lorenzen H, Welz A, Probst C. Retrograde autologous priming as a safe and easy method to reduce Hemodilution and transfusion requirements during cardiac surgery. Thorac Cardiovasc Surg. 2015;63(7):628–34.CrossRefPubMed
20.
go back to reference Hofmann B, Bushnaq H, Kraus FB, Raspe C, Simm A, Silber RE, Ludwig-Kraus B. Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy. Perfusion. 2013;28(5):412–8.CrossRefPubMed Hofmann B, Bushnaq H, Kraus FB, Raspe C, Simm A, Silber RE, Ludwig-Kraus B. Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy. Perfusion. 2013;28(5):412–8.CrossRefPubMed
21.
go back to reference Calafiore AM, Teodori G, Mezzetti A, Bosco G, Verna AM, Di Giammarco G, Lapenna D. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg. 1995;59(2):398–402.CrossRefPubMed Calafiore AM, Teodori G, Mezzetti A, Bosco G, Verna AM, Di Giammarco G, Lapenna D. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg. 1995;59(2):398–402.CrossRefPubMed
22.
go back to reference Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivates - 4th revised edition. Transfus Med Hemother. 2009;36(6):345–492.CrossRef Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivates - 4th revised edition. Transfus Med Hemother. 2009;36(6):345–492.CrossRef
23.
go back to reference Hoppe JD, Scriba PC, Kluter H. Cross-sectional guidelines for therapy with blood components and plasma derivatives (4th revised edition, 2008) - suspension of chapter 5 'Human albumin. Transfus Med Hemother. 2011;38(1):71.CrossRefPubMedPubMedCentral Hoppe JD, Scriba PC, Kluter H. Cross-sectional guidelines for therapy with blood components and plasma derivatives (4th revised edition, 2008) - suspension of chapter 5 'Human albumin. Transfus Med Hemother. 2011;38(1):71.CrossRefPubMedPubMedCentral
24.
go back to reference Muller MM, Geisen C, Zacharowski K, Tonn T, Seifried E. Transfusion of packed red cells: indications, triggers and adverse events. Dtsch Arztebl Int. 2015;112(29–30):507–17. quiz 518PubMedPubMedCentral Muller MM, Geisen C, Zacharowski K, Tonn T, Seifried E. Transfusion of packed red cells: indications, triggers and adverse events. Dtsch Arztebl Int. 2015;112(29–30):507–17. quiz 518PubMedPubMedCentral
25.
go back to reference Schechtman E. Odds ratio, relative risk, absolute risk reduction, and the number needed to treat--which of these should we use? Value Health. 2002;5(5):431–6.CrossRefPubMed Schechtman E. Odds ratio, relative risk, absolute risk reduction, and the number needed to treat--which of these should we use? Value Health. 2002;5(5):431–6.CrossRefPubMed
26.
go back to reference Boer C, Meesters MI, Milojevic M, Benedetto U, Bolliger D, von Heymann C, Jeppsson A, Koster A, Osnabrugge RL, Ranucci M, et al. 2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth. 2017; Boer C, Meesters MI, Milojevic M, Benedetto U, Bolliger D, von Heymann C, Jeppsson A, Koster A, Osnabrugge RL, Ranucci M, et al. 2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth. 2017;
27.
28.
go back to reference Weltert L, Rondinelli B, Bello R, Falco M, Bellisario A, Maselli D, Turani F, De Paulis R, Pierelli L. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion. 2015;55(7):1644–54.CrossRefPubMed Weltert L, Rondinelli B, Bello R, Falco M, Bellisario A, Maselli D, Turani F, De Paulis R, Pierelli L. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion. 2015;55(7):1644–54.CrossRefPubMed
29.
go back to reference Hogan M, Klein AA, Richards T. The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery. Eur J Cardiothorac Surg. 2015;47(2):218–26.CrossRefPubMed Hogan M, Klein AA, Richards T. The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery. Eur J Cardiothorac Surg. 2015;47(2):218–26.CrossRefPubMed
30.
go back to reference Sun P, Ji B, Sun Y, Zhu X, Liu J, Long C, Zheng Z. Effects of retrograde autologous priming on blood transfusion and clinical outcomes in adults: a meta-analysis. Perfusion. 2013;28(3):238–43.CrossRefPubMed Sun P, Ji B, Sun Y, Zhu X, Liu J, Long C, Zheng Z. Effects of retrograde autologous priming on blood transfusion and clinical outcomes in adults: a meta-analysis. Perfusion. 2013;28(3):238–43.CrossRefPubMed
Metadata
Title
Positive impact of retrograde autologous priming in adult patients undergoing cardiac surgery: a randomized clinical trial
Authors
Britt Hofmann
Claudia Kaufmann
Markus Stiller
Thomas Neitzel
Andreas Wienke
Rolf-Edgar Silber
Hendrik Treede
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2018
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-018-0739-0

Other articles of this Issue 1/2018

Journal of Cardiothoracic Surgery 1/2018 Go to the issue